相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Safety and immunologic effects of high-vs low-dose cholecalciferol in multiple sclerosis
Elias S. Sotirchos et al.
NEUROLOGY (2016)
Effect of Alfacalcidol on multiple sclerosis-related fatigue: A randomized, double-blind placebo-controlled study
Anat Achiron et al.
MULTIPLE SCLEROSIS JOURNAL (2015)
Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range
Xiang Wan et al.
BMC MEDICAL RESEARCH METHODOLOGY (2014)
Preventive effect of vitamin D3 supplementation on conversion of optic neuritis to clinically definite multiple sclerosis: a double blind, randomized, placebo-controlled pilot clinical trial
Hajar Derakhshandi et al.
ACTA NEUROLOGICA BELGICA (2013)
Vitamin D supplementation for patients with multiple sclerosis treated with interferon-beta: a randomized controlled trial assessing the effect on flu-like symptoms and immunomodulatory properties
Daniel Golan et al.
BMC NEUROLOGY (2013)
Vitamin D and multiple sclerosis
Sarah Hewer et al.
JOURNAL OF CLINICAL NEUROSCIENCE (2013)
Vitamin D status predicts new brain magnetic resonance imaging activity in multiple sclerosis
Ellen M. Mowry et al.
ANNALS OF NEUROLOGY (2012)
Environmental Risk Factors for Multiple Sclerosis: A Review with a Focus on Molecular Mechanisms
Cullen O'Gorman et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2012)
A randomised, double blind, placebo controlled trial with vitamin D3 as an add on treatment to interferon β-1b in patients with multiple sclerosis
Merja Soilu-Hanninen et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2012)
Effect of vitamin D3 supplementation on relapses, disease progression, and measures of function in persons with multiple sclerosis: exploratory outcomes from a double-blind randomised controlled trial
Margitta T. Kampman et al.
MULTIPLE SCLEROSIS JOURNAL (2012)
Effects of Adjunct Low-Dose Vitamin D on Relapsing-Remitting Multiple Sclerosis Progression: Preliminary Findings of a Randomized Placebo-Controlled Trial
Vahid Shaygannejad et al.
MULTIPLE SCLEROSIS INTERNATIONAL (2012)
Latitude is significantly associated with the prevalence of multiple sclerosis: a meta-analysis
Steve Simpson et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2011)
A randomized trial of high-dose vitamin D2 in relapsing-remitting multiple sclerosis
M. S. Stein et al.
NEUROLOGY (2011)
Higher 25-hydroxyvitamin D Is Associated with Lower Relapse Risk in Multiple Sclerosis
Steve Simpson et al.
ANNALS OF NEUROLOGY (2010)
Genome-wide association study identifies new multiple sclerosis susceptibility loci on chromosomes 12 and 20
Melanie Bahlo et al.
NATURE GENETICS (2009)
From vitamin D to hormone D: fundamentals of the vitamin D endocrine system essential for good health
Anthony W. Norman
AMERICAN JOURNAL OF CLINICAL NUTRITION (2008)
Association of vitamin D metabolite levels with relapse rate and disability in multiple sclerosis
J. Smolders et al.
MULTIPLE SCLEROSIS JOURNAL (2008)
Vitamin D levels in people with multiple sclerosis and community controls in Tasmania, Australia
I. A. F. van der Mei et al.
JOURNAL OF NEUROLOGY (2007)
Extra-renal 25-hydroxyvitamin D3-1α-hydroxylase in human health and disease
Martin Hewison et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2007)
A pilot study of oral calcitriol (1,25-dihydroxyvitamin D3) for relapsing-remitting multiple sclerosis
DM Wingerchuk et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2005)
Vitamin D intake and incidence of multiple sclerosis
KL Munger et al.
NEUROLOGY (2004)
Measuring inconsistency in meta-analyses
JPT Higgins et al.
BMJ-BRITISH MEDICAL JOURNAL (2003)
Recommended diagnostic criteria for multiple sclerosis: Guidelines from the International Panel on the Diagnosis of Multiple Sclerosis
WI McDonald et al.
ANNALS OF NEUROLOGY (2001)
分享论文
